Conference Coverage
Conference Coverage
Imaging Combo May Diagnose Gastric Cancer Without Biopsy
Major Finding: Magnifying NBI improves the diagnostic performance of white light endoscopy for discriminating gastric cancer from benign small...
Conference Coverage
Attention Turns to Concussions' Psychiatric Effects in Athletes
Conference Coverage
Studies Mixed on Second Cancers After Lenalidomide
Major Finding: At a median follow-up of 30 months, 12 of 150 (8%) patients on melphalan-prednisone plus lenalidomide with maintenance developed an...
Conference Coverage
Rich Patients With Poor Prognosis Cancers Get More Treatment
Major Finding: For the lowest socioeconomic group of patients with lung cancer, radiation therapy was given to 44%, surgery to 13%, and...
Conference Coverage
Transplant in First Remission Holds Off Progression in Non-Hodgkin's Lymphoma
Major Finding: Estimated 2-year progression-free survival was 69% among patients randomized to CHOP chemotherapy with/without rituximab plus...
Conference Coverage
European Trial Upholds Use of Erlotinib in EGFR-Mutant Lung Cancer
Major Finding: Erlotinib resulted in a significant 63% reduction in the risk of progression, compared with standard chemotherapy (HR 0.37).Data...
Conference Coverage
Rheumatoid Society Addresses Employment Disparity
Conference Coverage
Continued Aspirin Use Does Not Impede Ulcer Healing
Major Finding: The ulcer healing rate by intention-to-treat analysis was 85.2% with esomeprazole alone and 84.8% with esomeprazole plus aspirin....
Conference Coverage
Cyclosporine No Better Than Infliximab for Ulcerative Colitis
Major Finding: In the treatment of acute severe ulcerative colitis refractory to intravenous steroids, cyclosporine was not more effective than...
Conference Coverage
Video Report: Recession Impacts Cancer Screening, Treatment
Conference Coverage
Vancomycin Monotherapy Linked to C. Difficile Recurrence in IBD
Major Finding: The rate of C.